Skip to main content

Our new intranet / wiki is online!

A new wiki/ intranet for the Cluster of Excellence ImmunoSensation is now available for our member:

https://confluence.team.uni-bonn.de/x/n4hWAQ

Thereby we use Confluence form the University of Bonn, where some Uni institutions (like the HRZ or Human Resources Development) with their areas can already be found.

In our new wiki / intranet information about our funding opportunities; Software and Hardware within the Cluster or important documentes for e.g. travel expenses can be found.

Access to Confluence is available to all employees with an Uni-ID.The access to the area for the cluster is limited, that means you will not see the area in the overview at the beginning.Confluence can be reached via eduroam/bonnet network or by using the Uni-VPN client.

Only after you have registered in the following form and we have activated your account you will have access to our area.

Registration: https://www.umfrageonline.com/s/d070df5

In the attachment you will find an FAQ with all relevant links and details about the requirements for usage as well as further information (for example contents of the area).

If you have any questions or feedback regarding our Confluence area, please feel free to contact us.We are happy if the new wiki is used a lot and we can encourage a good exchange!

Related news

Children in the lab at "Girls' and Boys' Day 2026"

News categories: Outreach

Girls' & Boys' Day at ImmunoSensation³

The annual "Girls' & Boys' Day" (former "Girls' day") sets out to introduce children and young addults to careers their respective gender is still underrepresented in. To celebrate this special day and offer insights into the work of a biomedical researcher, we welcomed students from all over Germany to our laboratories. Besides hands-on science, career options and perspectives in research were discussed.
View entry
PM Immunity Nebeling

News categories: Publication

Study reveals dynamic interactions between brain tumors and immune cells

Glioblastoma, the most common and aggressive brain tumor in adults, is difficult to treat because this cancer can invade the surrounding brain tissue and spread far beyond the original tumor mass. Researchers from the DZNE, the University Hospital Bonn (UKB), and ImmunoSensation³ at the University of Bonn have observed this infiltration process in the living brain using high-tech microscopy. Their study is based on research in mice with a form of brain tumor that closely resembles human glioblastoma.
View entry
Nora Möhn

News categories: Publication

New Findings on Immunotherapy for a Rare Brain Infection

Progressive multifocal leukoencephalopathy (PML) is a rare but very serious brain disease. It is caused by the reactivation of the widespread JC virus when the immune system is severely weakened. There is currently no targeted antiviral therapy available, which is why new treatment approaches are urgently needed. In recent years, so-called immune checkpoint inhibitors have been increasingly used; these “unlock” the immune system and reactivate the body’s own immune cells. The results were recently published in the journal JAMA Neurology.
View entry

Back to the news overview